Structure Therapeutics Inc.
GPCR
$23.74
$0.090.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.06% | 345.56% | 312.81% | 81.20% | 414.44% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.40% | 84.45% | 188.91% | 143.93% | 179.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 88.17% | 339.92% | 310.84% | 82.55% | 408.77% |
|
|
|||||
| Total Current Assets | 88.17% | 339.92% | 310.84% | 82.55% | 408.77% |
| Net Property, Plant & Equipment | -16.15% | 27.77% | 549.14% | 586.39% | 546.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11,246.67% | 420.57% | 4,705.26% | -20.34% | -98.70% |
| Total Assets | 87.41% | 331.31% | 312.78% | 84.85% | 392.63% |
|
|
|||||
| Total Accounts Payable | 69.21% | 154.50% | -61.24% | 32.21% | -21.09% |
| Total Accrued Expenses | 41.71% | 50.48% | 107.17% | 161.90% | 182.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.92% | 109.55% | 2,131.51% | 852.38% | 453.85% |
| Total Finance Division Other Current Liabilities | -- | -76.03% | -76.70% | 185.58% | -- |
| Total Other Current Liabilities | -- | -76.03% | -76.70% | 185.58% | -- |
| Total Current Liabilities | 45.60% | 66.41% | 50.93% | 114.38% | 90.16% |
|
|
|||||
| Total Current Liabilities | 45.60% | 66.41% | 50.93% | 114.38% | 90.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -46.08% | -11.90% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.34% | 9.96% | -- | -- | -- |
| Total Liabilities | 32.48% | 55.58% | 73.16% | 149.11% | 123.30% |
|
|
|||||
| Common Stock & APIC | 81.03% | 216.13% | 216.39% | 78.51% | 34,188.09% |
| Retained Earnings | -59.31% | -60.72% | -63.48% | -72.40% | -76.63% |
| Treasury Stock & Other | 75.43% | 1,015.81% | -24.87% | -161.22% | 573.64% |
| Total Common Equity | 90.93% | 364.75% | 329.56% | 81.86% | 493.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.93% | 364.75% | 329.56% | 81.86% | 493.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.93% | 364.75% | 329.56% | 81.86% | 433.94% |
|
|
|||||